# Seborrheic Keratosis

Seborrheic keratosis is managed conservatively only after a sufficiently confident clinical and dermoscopic assessment. Biopsy lesions with diagnostic uncertainty or atypical features before destructive treatment, because melanoma, basal cell carcinoma, squamous cell carcinoma, and other epidermal tumors can mimic seborrheic keratosis.

**Clinical question:** When should a presumed seborrheic keratosis be biopsied, and which removal technique best fits a confirmed lesion?

Updated: 2026-09-15T23:48:25.558882+00:00

## What matters in practice
- Do not use cryotherapy or other destructive treatment for a lesion that is not confidently seborrheic keratosis clinically and dermoscopically; perform shave biopsy with histopathology when the diagnosis remains uncertain. [18]
- Use dermoscopy to seek supportive seborrheic keratosis structures, including milia-like cysts (white clods) and comedo-like openings; dermoscopy improves evaluation of melanomas that clinically resemble seborrheic keratosis. [1][2]
- For multiple, unequivocal lesions, cryosurgery is rapid and practical; thin flat lesions generally require a 5- to 10-second freeze-thaw cycle, while thicker lesions may need longer treatment or two cycles. [21][22]
- Select shave removal or curettage with electrodesiccation when histology is needed or when immediate lesion removal is preferred; counsel regarding infection, scarring, hyperpigmentation, and incomplete removal or recurrence. [18][19]
- Acute eruption of multiple pruritic seborrheic keratoses warrants assessment for Leser-Trélat–associated malignancy, while a similar inflammatory presentation during chemotherapy may represent pseudo–Leser-Trélat. [21]

## Decide whether the lesion can be treated as seborrheic keratosis

The central management decision is diagnostic confidence before destruction.

Manage conservatively when the lesion is clinically and dermoscopically unequivocal and does not create cosmetic or functional concern. Removal is appropriate for symptoms, function, or cosmesis, but destructive treatment should not substitute for diagnostic assessment in an atypical lesion. [21][24]

Perform dermoscopy before treatment when the clinical impression is seborrheic keratosis but pigmentation, inflammation, architectural irregularity, or a changing history creates uncertainty. Milia-like cysts (white clods) and comedo-like openings support seborrheic keratosis; dermoscopy also improves diagnostic accuracy for melanomas that clinically resemble seborrheic keratosis. [1][2]

If the lesion remains equivocal after clinical examination and dermoscopy, use shave biopsy or another tissue-sampling approach that preserves diagnostic material rather than cryotherapy, cautery, or chemical ablation. Shave excision is specifically indicated for lesions not unequivocally diagnosed clinically and/or dermoscopically and permits histopathologic examination. [18]
- Biopsy rather than destroy when the lesion cannot be confidently separated from melanoma, pigmented basal cell carcinoma, cutaneous squamous cell carcinoma, actinic keratosis, wart, lichenoid keratosis, or a melanocytic nevus. [12][13][15]
- Treat dermoscopy as an adjunct, not a replacement for histopathology, when concerning morphology persists or the examination is discordant with the clinical history. [1][18]
- Avoid assuming that a stuck-on clinical appearance excludes melanoma; melanomas may clinically resemble seborrheic keratosis. [1][3]

*Diagnostic pathway before lesion-directed treatment. [1][2][18]*

| Clinical scenario | Next action | Management consequence |
| --- | --- | --- |
| Typical lesion with concordant clinical and dermoscopic seborrheic keratosis features | No tissue test required before observation or elective removal. [2][21] | Choose no treatment or lesion-directed removal based on symptoms, function, and cosmetic goals. [21][24] |
| Pigmented, inflamed, atypical, or otherwise diagnostically uncertain lesion | Perform dermoscopy; assess for supportive seborrheic keratosis structures and competing malignant patterns. [1][2][15] | If uncertainty resolves, treat as confirmed lesion; if uncertainty persists, obtain histopathology. [18] |
| Lesion not unequivocally seborrheic keratosis after examination and dermoscopy | Perform shave biopsy/excision and submit the specimen for histopathology. [18] | Defer cryotherapy, electrodesiccation, laser, and chemical destruction until diagnosis is established. [18][19] |

## Separate seborrheic keratosis from high-consequence mimics

The decision threshold for biopsy is lower when a malignant mimic is plausible.

Melanoma is the most consequential mimic when a pigmented lesion is labeled seborrheic keratosis. Because melanomas can clinically resemble seborrheic keratosis and dermoscopy improves accuracy in this setting, do not rely on morphology alone when a lesion is atypical or its features are not fully concordant. [1][3]

Consider basal cell carcinoma when an apparent seborrheic keratosis is a well-demarcated elevated lesion with ulceration or fine telangiectatic vessels. Pigmented basal cell carcinoma may also resemble a melanocytic lesion, and tissue diagnosis may require immunohistochemistry when standard histology is insufficient for categorization. [13]

Consider actinic keratosis or cutaneous squamous cell carcinoma in keratotic lesions with a sun-damage context or a persistent thick/indurated component. Thick and indurated actinic keratoses should undergo biopsy to exclude squamous cell carcinoma; irritated seborrheic keratosis is itself a recognized dermoscopic differential diagnosis for squamous cell carcinoma. [12][15]
- Potential benign mimics: verruca, lichenoid keratosis, and melanocytic nevus. [12]
- Potential malignant mimics: melanoma, pigmented basal cell carcinoma, superficial basal cell carcinoma, and cutaneous squamous cell carcinoma. [1][12][13][15]
- For uncertain lesions, choose a diagnostic procedure that yields tissue rather than a destructive modality that eliminates the histologic specimen. [18]

### Eruptive lesions

A sudden onset of multiple pruritic seborrheic keratoses is described as the Leser-Trélat sign and has been associated with gastrointestinal adenocarcinoma, lymphoma, Sézary syndrome, and acute leukemia. In this pattern, document timing, associated pruritus, systemic symptoms, medication exposure, and age-appropriate cancer screening status; direct further evaluation toward any history or examination findings suggesting an underlying malignancy. [21]

Differentiate pseudo–Leser-Trélat from a paraneoplastic eruption when pruritus and erythema develop in pre-existing multiple seborrheic keratoses during chemotherapy. The temporal medication relationship changes the interpretation and may prevent attributing an inflammatory treatment reaction to occult cancer alone. [21]

*Actionable differential diagnoses for an apparent seborrheic keratosis. [1][12][13][15][18]*

| Competing diagnosis | Discriminator from available evidence | Next step |
| --- | --- | --- |
| Melanoma | May clinically resemble seborrheic keratosis. [1][3] | Use dermoscopy; biopsy if the lesion remains nonclassic or equivocal. [1][18] |
| Basal cell carcinoma | Elevated, well-demarcated lesion with ulceration or fine telangiectatic vessels; pigmented lesions may mimic melanocytic lesions. [13] | Obtain tissue diagnosis rather than destructive treatment when suspected. [13][18] |
| Actinic keratosis or cutaneous squamous cell carcinoma | Thick or indurated keratotic lesion; irritated seborrheic keratosis can overlap dermoscopically with squamous cell carcinoma. [12][15] | Biopsy thick or indurated lesions to exclude squamous cell carcinoma. [12] |
| Verruca or lichenoid keratosis | Recognized clinical differential diagnoses. [12] | Use dermoscopy and biopsy if the diagnosis remains uncertain. [2][18] |

## Choose removal technique by lesion burden, need for pathology, and cosmetic tradeoff

No intervention is required for a confirmed asymptomatic lesion.

Observation is appropriate for unequivocal seborrheic keratosis without patient concern. When removal is requested, select the procedure according to number of lesions, thickness, site, cosmetic importance, and whether tissue confirmation is required. Common operative approaches include cryotherapy, shave excision, curettage, electrodesiccation, and laser ablation. [19][21][24]

Use shave excision when diagnostic tissue is required or when a superficial epidermal lesion is best removed in one procedure. The procedure is usually performed under local anesthesia, commonly 1% lidocaine with or without epinephrine depending on site; submit the specimen for histopathology when diagnosis was not unequivocal before removal. [18]

Use electrodesiccation with or without curettage for superficial epidermal lesions when histologic uncertainty has been resolved or tissue sampling has already been obtained. The technique uses curettage followed by repeated electrodesiccation with a hyfrecator or cautery unit; counsel about infection, scarring, and hyperpigmentation. [18]

Consider ablative laser removal for selected lesions when cosmetic outcome is prioritized and equipment/expertise are available. In a comparative report, erbium:YAG laser achieved complete healing in all treated lesions versus 68% in the cryotherapy group, with less hyperpigmentation reported for laser than cryotherapy; this evidence does not eliminate the need for diagnostic confirmation before ablation. [20]
- Use local anesthetic for shave removal and for curettage/electrodesiccation when needed for procedural comfort. [18]
- Counsel before any destructive intervention about scarring, pigmentary alteration, incomplete removal, and recurrence. [19][23]
- Avoid topical or systemic drug therapy as routine eradication treatment; neither has established viable routine treatment use for seborrheic keratosis. [7]

*Procedure selection for confirmed seborrheic keratosis. [18][20][21][22][23]*

| Procedure | Best use | Technique or timing | Key tradeoff |
| --- | --- | --- | --- |
| Cryosurgery | Multiple confirmed lesions, especially when rapid treatment is preferred. [21][22] | Thin, flat lesions generally require a 5- to 10-second freeze-thaw cycle; thicker lesions may require longer treatment or two cycles. [22] | Blistering and crusting are expected; hypopigmentation, scarring, nerve injury, and recurrence are possible. [23] |
| Shave excision | Diagnostic uncertainty or desire for immediate superficial lesion removal. [18] | Use local anesthesia, commonly 1% lidocaine with or without epinephrine depending on site; send specimen for histopathology when diagnosis is uncertain. [18] | Provides tissue diagnosis but is a surgical removal procedure. [18] |
| Curettage with electrodesiccation | Superficial epidermal lesion after diagnostic confidence is established. [18] | Curette epidermal tissue, then repeat electrodesiccation with hyfrecator or cautery as needed for removal. [18] | Infection, scarring, and hyperpigmentation can occur. [18] |
| Ablative laser | Selected lesions when cosmetic result is a priority and expertise is available. [20] | Laser ablation is an established procedural option; confirm diagnosis before ablation. [19][20] | Comparative data suggest less hyperpigmentation than cryotherapy in one report, but access and procedural cost may limit use. [20] |

## Use cryotherapy only after confirming lesion identity

Cryosurgery is efficient for a burden of clearly benign lesions.

Cryotherapy is a commonly used approach for seborrheic keratosis and is particularly practical when several confirmed lesions are treated during the same visit. It was the preferred method reported by U.S. board-certified dermatologists in a survey, and patients in a small comparative study preferred cryotherapy over curettage. [21]

Tailor the freeze duration to lesion thickness: thin, flat lesions usually require a 5- to 10-second freeze-thaw cycle, while larger or thicker lesions may need a longer application or two freeze-thaw cycles. If residual lesion persists, repeat treatment can be performed at 3- to 4-week intervals until resolution. [22][23]

Set expectations before treatment: erythema, blistering, and crusting are expected after cryotherapy, and healing generally occurs over several weeks. Discuss hypopigmentation, scarring, nerve injury, recurrence, and potential hair loss in treated hair-bearing areas when selecting the modality. [22][23]
- Do not cryotreat an atypical pigmented or inflamed lesion before dermoscopic assessment and biopsy when uncertainty persists. [1][18]
- Reassess lesions that fail to behave as expected after treatment rather than repeatedly treating an unverified diagnosis. Histopathology is the next diagnostic step when the original diagnosis was not unequivocal. [18]
- For cosmetically sensitive sites, weigh pigmentary risk against shave removal, curettage/electrodesiccation, or laser options. [18][20][23]

*Cryotherapy counseling and follow-up for confirmed seborrheic keratosis. [22][23]*

| Time point | Expected finding or action | Escalation |
| --- | --- | --- |
| Before treatment | Confirm diagnosis clinically and dermoscopically; identify lesion margins and thickness. [1][2][23] | Biopsy rather than freeze if diagnosis remains uncertain. [18] |
| Immediately after treatment | Explain that erythema, blistering, and crusting may occur. [23] | Counsel on pigment change, scarring, nerve injury, recurrence, and hair loss risk in hair-bearing areas. [22][23] |
| Follow-up | Healing generally occurs over several weeks; larger or thicker lesions may require repeated treatment at 3- to 4-week intervals. [23] | If the lesion was never unequivocal or remains clinically concerning, obtain histopathology rather than continue empiric destruction. [18] |

## Document diagnostic confidence and reassess nonresolving lesions

The record should make clear why tissue diagnosis was or was not obtained.

Before elective destruction, document the lesion site, morphology, diagnostic impression, dermoscopic findings when performed, and whether the lesion was unequivocal. This documentation is particularly important for pigmented or irritated lesions because melanoma, basal cell carcinoma, and squamous cell carcinoma may imitate seborrheic keratosis. [1][13][15][18]

For biopsy or shave excision, link the pathology request to the clinical differential rather than submitting a nonspecific specimen. Histopathology is the definitive next step for lesions not confidently diagnosed as seborrheic keratosis on clinical and dermoscopic assessment. [18]

After cryotherapy, curettage/electrodesiccation, or laser ablation, reassess when persistence, recurrence, or an atypical residual morphology raises doubt about the original diagnosis. Repeated destructive treatment should not delay tissue diagnosis of a lesion that was not unequivocal at baseline. [18][19][23]
- Record the procedure selected and the counseling provided about pigmentary change, scar, infection, recurrence, and healing expectations. [18][19][23]
- For eruptive pruritic lesions, record onset, distribution, chemotherapy exposure, and findings that guide evaluation for Leser-Trélat or pseudo–Leser-Trélat. [21]

*Minimum decision-relevant documentation for seborrheic keratosis management. [18][21][23]*

| Encounter element | Document | Why it changes care |
| --- | --- | --- |
| Diagnostic assessment | Clinical impression, dermoscopic features, and diagnostic certainty. [1][2] | Supports observation or destruction only when seborrheic keratosis is sufficiently certain; otherwise triggers biopsy. [18] |
| Procedure choice | Whether cryotherapy, shave excision, curettage/electrodesiccation, or laser was selected and why. [18][19][20] | Clarifies whether pathology was required and frames expected adverse effects. [18][23] |
| Eruptive presentation | Abrupt onset, pruritus, chemotherapy timing, and associated clinical findings. [21] | Distinguishes possible Leser-Trélat association from pseudo–Leser-Trélat and guides targeted assessment. [21] |

## References
1. Skin Cancer Diagnosis by Lesion, Physician, and Examination Type — jamanetwork.com — https://jamanetwork.com/journals/jamadermatology/fullarticle/2826310
2. Dermoscopic Clues for Diagnosing Seborrheic Keratosis ... — jamanetwork.com — https://jamanetwork.com/journals/jamadermatology/fullarticle/2612723
3. Prevalence of Melanoma Clinically Resembling Seborrheic Keratosis — jamanetwork.com — https://jamanetwork.com/journals/jamadermatology/fullarticle/479107
4. Effectiveness of Cryosurgery vs Curettage in the Treatment of ... — jamanetwork.com — https://jamanetwork.com/journals/jamadermatology/fullarticle/1557760
5. Seborrheic keratosis - Wiley Online Library — onlinelibrary.wiley.com — https://onlinelibrary.wiley.com/doi/pdf/10.1111/ddg.14984
6. Frequency of Seborrheic Keratosis Biopsies in the United States: A ... — onlinelibrary.wiley.com — https://onlinelibrary.wiley.com/doi/abs/10.1046/j.1524-4725.2003.29211.x
7. Seborrheic keratosis - Hafner - 2008 - JDDG - Wiley Online Library — onlinelibrary.wiley.com — https://onlinelibrary.wiley.com/doi/full/10.1111/j.1610-0387.2008.06788.x
8. Seborrheic keratosis - Barthelmann - 2023 - Wiley Online Library — onlinelibrary.wiley.com — https://onlinelibrary.wiley.com/doi/full/10.1111%2Fddg.14984
9. The sensitivity and specificity of optical coherence tomography for ... — academic.oup.com — https://academic.oup.com/bjd/article/173/2/428/6616476
10. Heavily pigmented lesion on the breast of a 51-year-old woman — academic.oup.com — https://academic.oup.com/ced/article/51/1/195/8273662
11. Health Utilities for Non-Melanoma Skin Cancers and Pre ... — academic.oup.com — https://academic.oup.com/skinhd/article/1/3/ski2.51/7733934
12. Keratosis - an overview | ScienceDirect Topics — www.sciencedirect.com — https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/keratosis
13. Basal Cell Carcinoma - an overview | ScienceDirect Topics — www.sciencedirect.com — https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/basal-cell-carcinoma
14. Cutaneous squamous cell carcinoma: Incidence, risk factors, diagnosis, and staging - ScienceDirect — www.sciencedirect.com — https://www.sciencedirect.com/science/article/pii/S0190962217323253
15. Accuracy of dermoscopic criteria for the differential diagnosis between irritated seborrheic keratosis and squamous cell carcinoma - ScienceDirect — www.sciencedirect.com — https://www.sciencedirect.com/science/article/abs/pii/S0190962220302279
16. Combo Immunotx in HPV OPSCC Version Date: 09.20.2023 — cdn.clinicaltrials.gov — https://cdn.clinicaltrials.gov/large-docs/97/NCT04432597/Prot_SAP_003.pdf
17. July 10, 2019 — cdn.clinicaltrials.gov — https://cdn.clinicaltrials.gov/large-docs/92/NCT04439292/Prot_001.pdf
18. Seborrheic Keratosis - StatPearls - NCBI Bookshelf — www.ncbi.nlm.nih.gov — https://www.ncbi.nlm.nih.gov/books/NBK545285
19. Unusual clinical manifestation of seborrheic keratosis on the scalp successfully treated with topical trichloroacetic acid: an atypical case report — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC7757303
20. A split-face study comparing the efficacy and tolerability of erbium YAG laser and 70% trichloroacetic acid in facial seborrheic keratosis - PMC — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC11086929
21. Differential Diagnosis and Management on Seborrheic Keratosis in Elderly Patients - PMC — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC8088980
22. Clinical practice trends in cryosurgery: a retrospective study of ... — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC4436237
23. Cryotherapy in Dermatology - StatPearls - NCBI Bookshelf — www.ncbi.nlm.nih.gov — https://www.ncbi.nlm.nih.gov/books/NBK482319
24. Update of pathophysiology and treatment options of seborrheic ... — pubmed.ncbi.nlm.nih.gov — https://pubmed.ncbi.nlm.nih.gov/36226729

## Editorial note

Prepared from cited clinical literature using Astra's research workflow. Verify recommendations against current guidance and patient-specific factors.